DCLK1 regulates the EMT process in pancreatic, liver, kidney, and colorectal cancers; knockdown of DCLK1 results in decreased cancer growth, EMT, and metastasis [9,11–15,66,80]. This evidence concerns the gene DCLK1 and colorectal cancer.